在癌症免疫疗法中准泛素特异蛋白酶 (USPs):从基础研究到临床前应用
Hongli Gao1, Jianqiao Yin1, Ce Ji2
1Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Journal of experimental & clinical cancer research : CR
|September 1, 2023
概括
准泛素特异蛋白酶 (USP) 提供了一种新的策略,以增强癌症免疫疗法. 抑制USPs可以克服瘤免疫逃避,提高治疗疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 瘤使用多种机制来逃避免疫监测,阻碍抗瘤反应并促进进展.
- 由双双化酶 (DUB) 调节的无素-蛋白酶系统 (UPS) 对于蛋白质降解和免疫调节至关重要.
- 乌比基特异蛋白酶 (USP),一个主要的DUB家族,显著影响免疫细胞功能,免疫反应和瘤中的抗原呈现.
研究的目的:
- 探索准泛素特异蛋白酶 (USPs) 作为癌症免疫治疗的新策略的潜力.
- 审查最近关于USP抑制剂用于增强抗瘤免疫力的基础和临床前研究.
- 为癌症免疫系统的USP结构和功能提供见解,以指导新的治疗开发.
主要方法:
- 对最近的基础和临床前研究的文献综述.
- 分析USPs在瘤免疫逃避和瘤免疫微环境中的作用.
- 探索USP抑制剂作为潜在的免疫治疗剂.
主要成果:
- USP家族成员参与瘤免疫逃脱和塑造免疫微环境.
- 在临床前模型中,USP抑制剂在增强抗瘤免疫反应方面表现有前途.
- 针对USPs是克服免疫疗法耐药性的潜在途径.
结论:
- 乌比基特异蛋白酶 (USP) 是癌症免疫系统的关键调节者.
- 抑制USPs可能会逆转瘤诱导的免疫抑制,并提高免疫治疗的疗效.
- 对USP抑制剂的进一步研究可能会导致改善癌症治疗策略.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.5K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
Cancer Vaccines
400
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
400
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
